Synopsis of recent research by authors named "Abel Oliva"
- Abel Oliva's research primarily focuses on the development and evaluation of biodegradable nanoparticles and natural carrier systems for topical drug delivery, particularly in the treatment of skin diseases and infections.
- His studies have demonstrated the potential for various biocompatible nanoparticles, such as poly(octamethylene suberate) and plant-oil-based carriers, to effectively encapsulate therapeutic molecules, enhancing their stability and delivery efficacy.
- Additionally, Oliva's work includes exploring innovative in vitro skin models, including skin-on-a-chip technologies, to improve drug testing protocols and assess the safety and effectiveness of new therapeutic agents, ultimately aiming to reduce animal testing.